Cedax
WikiDoc Resources for Cedax |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cedax at Clinical Trials.gov Clinical Trials on Cedax at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cedax
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Cedax Risk calculators and risk factors for Cedax
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
CEDAX is an antibiotic known as ceftibuten. Each capsule contains 400 mg of ceftibuten.
Indications: CEDAX is active against:
Haemophilus influenzae
Escherichia coli (K. pneumoniae, K. oxytoca)
Proteus vulgaris, P. mirabils, P. providence
Species of Salmonella and Shigellas
Species of Enterobacter
CEDAX is indicated for acute bronchitis, pneumonias and urinary track infections, enteritis and gastroenteritis.
Dosage: 5 to 10 days. Adults recommended dose is 400 mg/day. Children 9 mg/kg/day (max. 400 mg). Best taken in an empty stomach ( at least 1 hour before a meal, or at least 2 hours after a meal).
Adverse reactions: In studies made in 3,000 patients CEDAX was well tolerated . Most frequent reactions were gastrointestinal and nauseas.
Warning: Must be prescribed with extreme caution in individuals with allergy to penicillins.
Sources: Medicohomepage, Cedax